PMID- 7852845 OWN - NLM STAT- MEDLINE DCOM- 19950314 LR - 20190516 IS - 0741-5400 (Print) IS - 0741-5400 (Linking) VI - 57 IP - 2 DP - 1995 Feb TI - Cyclic GMP and guanylate cyclase mediate lipopolysaccharide-induced Kupffer cell tumor necrosis factor-alpha synthesis. PG - 297-302 AB - Tumor necrosis factor-alpha (TNF-alpha) is an important mediator in sepsis and septic shock. Kupffer cells (KCs) are the resident macrophages of the liver and are potent producers of TNF-alpha in response to inflammatory stimuli such as bacterial endotoxin or lipopolysaccharide (LPS). Although the effects of exogenous cytokines such as interferon-gamma on TNF-alpha production by macrophages have been fairly well studied, the intracellular pathways regulating KC TNF-alpha synthesis are largely unknown. We investigated the role of guanylate cyclase and cGMP in LPS-induced KC TNF-alpha synthesis. Exogenous 8-BrcGMP and dbcGMP increased LPS-stimulated TNF-alpha synthesis but had no effect on KC TNF-alpha in the absence of LPS. Sodium nitroprusside (SNP), a nitric oxide-releasing substance that stimulates guanylate cyclase, increased TNF-alpha synthesis in response to LPS, whereas methylene blue and LY83583, guanylate cyclase inhibitors, decreased KC TNF-alpha synthesis. The inhibitory effect of methylene blue could be overcome with exogenous dbcGMP or SNP. Our results demonstrate that guanylate cyclase and cGMP mediate LPS-induced KC TNF-alpha synthesis and suggest that agents that alter cyclic nucleotide metabolism in KCs may affect the response of these cells to inflammation and inflammatory stimuli. FAU - Harbrecht, B G AU - Harbrecht BG AD - Department of Surgery, University of Pittsburgh, Pennsylvania. FAU - Wang, S C AU - Wang SC FAU - Simmons, R L AU - Simmons RL FAU - Billiar, T R AU - Billiar TR LA - eng GR - GM-37753/GM/NIGMS NIH HHS/United States GR - GM-44100/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - J Leukoc Biol JT - Journal of leukocyte biology JID - 8405628 RN - 0 (Aminoquinolines) RN - 0 (Lipopolysaccharides) RN - 0 (SRS-A) RN - 0 (Tumor Necrosis Factor-alpha) RN - 169D1260KM (Nitroprusside) RN - 31356-94-2 (8-bromocyclic GMP) RN - 31C4KY9ESH (Nitric Oxide) RN - 32266-35-6 (Dibutyryl Cyclic GMP) RN - 91300-60-6 (6-anilino-5,8-quinolinedione) RN - EC 4.6.1.2 (Guanylate Cyclase) RN - H2D2X058MU (Cyclic GMP) RN - T42P99266K (Methylene Blue) SB - IM MH - Aminoquinolines/pharmacology MH - Animals MH - Cell Membrane Permeability MH - Cells, Cultured MH - Cyclic GMP/analogs & derivatives/pharmacology/*physiology MH - Dibutyryl Cyclic GMP/pharmacology MH - Guanylate Cyclase/antagonists & inhibitors/drug effects/*physiology MH - Kupffer Cells/drug effects/metabolism/*physiology MH - Lipopolysaccharides/*pharmacology MH - Male MH - Methylene Blue/pharmacology MH - Nitric Oxide/metabolism MH - Nitroprusside/pharmacology MH - Rats MH - Rats, Sprague-Dawley MH - SRS-A/antagonists & inhibitors MH - Second Messenger Systems/drug effects/physiology MH - Stimulation, Chemical MH - Tumor Necrosis Factor-alpha/*biosynthesis EDAT- 1995/02/01 00:00 MHDA- 1995/02/01 00:01 CRDT- 1995/02/01 00:00 PHST- 1995/02/01 00:00 [pubmed] PHST- 1995/02/01 00:01 [medline] PHST- 1995/02/01 00:00 [entrez] AID - 10.1002/jlb.57.2.297 [doi] PST - ppublish SO - J Leukoc Biol. 1995 Feb;57(2):297-302. doi: 10.1002/jlb.57.2.297.